{"id":"https://openalex.org/W2016107761","doi":"https://doi.org/10.1016/0192-0561(87)90105-6","title":"Immunological abnormalities in rats with adjuvant-induced arthritis \u2014 II. Effect of antiarthritic therapy on immune function in relation to disease development","display_name":"Immunological abnormalities in rats with adjuvant-induced arthritis \u2014 II. Effect of antiarthritic therapy on immune function in relation to disease development","publication_year":1987,"publication_date":"1987-01-01","ids":{"openalex":"https://openalex.org/W2016107761","doi":"https://doi.org/10.1016/0192-0561(87)90105-6","mag":"2016107761","pmid":"https://pubmed.ncbi.nlm.nih.gov/3495501"},"language":"en","primary_location":{"id":"doi:10.1016/0192-0561(87)90105-6","doi":"https://doi.org/10.1016/0192-0561(87)90105-6","is_oa":false,"landing_page_url":"https://doi.org/10.1016/0192-0561(87)90105-6","pdf_url":null,"source":{"id":"https://openalex.org/S112303464","display_name":"International Journal of Immunopharmacology","issn_l":"0192-0561","issn":["0192-0561","1879-3495"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"International Journal of Immunopharmacology","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5111831481","display_name":"Steven C. Gilman","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4403928396","display_name":"Wyeth","ror":"https://ror.org/035j24j42","country_code":"US","type":"company","lineage":["https://openalex.org/I180857899","https://openalex.org/I4403928396"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Steven C. Gilman","raw_affiliation_strings":["Division of Experimental Therapeutics, Wyeth Laboratories, Inc., P.O. Box 8299, Philadelphia, PA 19101, U.S.A"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Experimental Therapeutics, Wyeth Laboratories, Inc., P.O. Box 8299, Philadelphia, PA 19101, U.S.A","institution_ids":["https://openalex.org/I4403928396"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5110199187","display_name":"Richard P. Carlson","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4403928396","display_name":"Wyeth","ror":"https://ror.org/035j24j42","country_code":"US","type":"company","lineage":["https://openalex.org/I180857899","https://openalex.org/I4403928396"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Richard P. Carlson","raw_affiliation_strings":["Division of Experimental Therapeutics, Wyeth Laboratories, Inc., P.O. Box 8299, Philadelphia, PA 19101, U.S.A"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Experimental Therapeutics, Wyeth Laboratories, Inc., P.O. Box 8299, Philadelphia, PA 19101, U.S.A","institution_ids":["https://openalex.org/I4403928396"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5071420106","display_name":"John F. Daniels","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4403928396","display_name":"Wyeth","ror":"https://ror.org/035j24j42","country_code":"US","type":"company","lineage":["https://openalex.org/I180857899","https://openalex.org/I4403928396"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"John F. Daniels","raw_affiliation_strings":["Division of Experimental Therapeutics, Wyeth Laboratories, Inc., P.O. Box 8299, Philadelphia, PA 19101, U.S.A"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Experimental Therapeutics, Wyeth Laboratories, Inc., P.O. Box 8299, Philadelphia, PA 19101, U.S.A","institution_ids":["https://openalex.org/I4403928396"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5089772341","display_name":"Louis J. Datko","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4403928396","display_name":"Wyeth","ror":"https://ror.org/035j24j42","country_code":"US","type":"company","lineage":["https://openalex.org/I180857899","https://openalex.org/I4403928396"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Louis Datko","raw_affiliation_strings":["Division of Experimental Therapeutics, Wyeth Laboratories, Inc., P.O. Box 8299, Philadelphia, PA 19101, U.S.A"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Experimental Therapeutics, Wyeth Laboratories, Inc., P.O. Box 8299, Philadelphia, PA 19101, U.S.A","institution_ids":["https://openalex.org/I4403928396"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5028792907","display_name":"Pamela R. Berner","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4403928396","display_name":"Wyeth","ror":"https://ror.org/035j24j42","country_code":"US","type":"company","lineage":["https://openalex.org/I180857899","https://openalex.org/I4403928396"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Pamela R. Berner","raw_affiliation_strings":["Division of Experimental Therapeutics, Wyeth Laboratories, Inc., P.O. Box 8299, Philadelphia, PA 19101, U.S.A"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Experimental Therapeutics, Wyeth Laboratories, Inc., P.O. Box 8299, Philadelphia, PA 19101, U.S.A","institution_ids":["https://openalex.org/I4403928396"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5102254194","display_name":"JOSEPH Y. CHANG","orcid":"https://orcid.org/0000-0002-1704-2755","observed_orcids":["https://orcid.org/0000-0002-1704-2755"]},"institutions":[{"id":"https://openalex.org/I4403928396","display_name":"Wyeth","ror":"https://ror.org/035j24j42","country_code":"US","type":"company","lineage":["https://openalex.org/I180857899","https://openalex.org/I4403928396"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Joseph Chang","raw_affiliation_strings":["Division of Experimental Therapeutics, Wyeth Laboratories, Inc., P.O. Box 8299, Philadelphia, PA 19101, U.S.A"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Experimental Therapeutics, Wyeth Laboratories, Inc., P.O. Box 8299, Philadelphia, PA 19101, U.S.A","institution_ids":["https://openalex.org/I4403928396"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5004166505","display_name":"Alan J. Lewis","orcid":"https://orcid.org/0000-0003-2105-9813","observed_orcids":["https://orcid.org/0000-0003-2105-9813"]},"institutions":[{"id":"https://openalex.org/I4403928396","display_name":"Wyeth","ror":"https://ror.org/035j24j42","country_code":"US","type":"company","lineage":["https://openalex.org/I180857899","https://openalex.org/I4403928396"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Alan J. Lewis","raw_affiliation_strings":["Division of Experimental Therapeutics, Wyeth Laboratories, Inc., P.O. Box 8299, Philadelphia, PA 19101, U.S.A"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Experimental Therapeutics, Wyeth Laboratories, Inc., P.O. Box 8299, Philadelphia, PA 19101, U.S.A","institution_ids":["https://openalex.org/I4403928396"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":["https://openalex.org/I4403928396"],"apc_list":null,"apc_paid":null,"fwci":2.0585,"has_fulltext":false,"cited_by_count":27,"citation_normalized_percentile":{"value":0.86474599,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":93},"biblio":{"volume":"9","issue":"1","first_page":"9","last_page":"16"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10200","display_name":"Rheumatoid Arthritis Research and Therapies","score":0.9868000149726868,"subfield":{"id":"https://openalex.org/subfields/2745","display_name":"Rheumatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10200","display_name":"Rheumatoid Arthritis Research and Therapies","score":0.9868000149726868,"subfield":{"id":"https://openalex.org/subfields/2745","display_name":"Rheumatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T13026","display_name":"Natural Compounds in Disease Treatment","score":0.008899999782443047,"subfield":{"id":"https://openalex.org/subfields/2707","display_name":"Complementary and alternative medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T14072","display_name":"Immunotoxicology and immune responses","score":0.0012000000569969416,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/adjuvant-induced-arthritis","display_name":"adjuvant-induced arthritis","score":0.9319999814033508},{"id":"https://openalex.org/keywords/immunomodulators","display_name":"immunomodulators","score":0.7009999752044678},{"id":"https://openalex.org/keywords/disease-modifying-therapy","display_name":"disease-modifying therapy","score":0.6579999923706055},{"id":"https://openalex.org/keywords/indomethacin","display_name":"indomethacin","score":0.8140000104904175},{"id":"https://openalex.org/keywords/levamisole","display_name":"levamisole","score":1.0},{"id":"https://openalex.org/keywords/paw-edema","display_name":"paw edema","score":0.8069999814033508},{"id":"https://openalex.org/keywords/bone-erosion","display_name":"bone erosion","score":0.9869999885559082},{"id":"https://openalex.org/keywords/rats","display_name":"rats","score":0.3880000114440918}],"concepts":[{"id":"https://openalex.org/C8891405","wikidata":"https://www.wikidata.org/wiki/Q1059","display_name":"Immune system","level":2,"score":0.7079620361328125},{"id":"https://openalex.org/C2779134260","wikidata":"https://www.wikidata.org/wiki/Q12136","display_name":"Disease","level":2,"score":0.6648924946784973},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.6223810911178589},{"id":"https://openalex.org/C2777863537","wikidata":"https://www.wikidata.org/wiki/Q357896","display_name":"Adjuvant","level":2,"score":0.5735774040222168},{"id":"https://openalex.org/C2777077863","wikidata":"https://www.wikidata.org/wiki/Q170990","display_name":"Arthritis","level":2,"score":0.5667635798454285},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.5189335346221924},{"id":"https://openalex.org/C14036430","wikidata":"https://www.wikidata.org/wiki/Q3736076","display_name":"Function (biology)","level":2,"score":0.42396289110183716},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.23193278908729553},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.12358951568603516},{"id":"https://openalex.org/C78458016","wikidata":"https://www.wikidata.org/wiki/Q840400","display_name":"Evolutionary biology","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D001168","descriptor_name":"Arthritis","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":true},{"descriptor_ui":"D001169","descriptor_name":"Arthritis, Experimental","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":false},{"descriptor_ui":"D001169","descriptor_name":"Arthritis, Experimental","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":true},{"descriptor_ui":"D001562","descriptor_name":"Benzimidazoles","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D002478","descriptor_name":"Cells, Cultured","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007166","descriptor_name":"Immunosuppressive Agents","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D007213","descriptor_name":"Indomethacin","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D007376","descriptor_name":"Interleukin-2","qualifier_ui":"Q000096","qualifier_name":"biosynthesis","is_major_topic":false},{"descriptor_ui":"D007978","descriptor_name":"Levamisole","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008809","descriptor_name":"Mice, Inbred C3H","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011919","descriptor_name":"Rats, Inbred Strains","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D051379","descriptor_name":"Mice","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D051381","descriptor_name":"Rats","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1016/0192-0561(87)90105-6","doi":"https://doi.org/10.1016/0192-0561(87)90105-6","is_oa":false,"landing_page_url":"https://doi.org/10.1016/0192-0561(87)90105-6","pdf_url":null,"source":{"id":"https://openalex.org/S112303464","display_name":"International Journal of Immunopharmacology","issn_l":"0192-0561","issn":["0192-0561","1879-3495"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"International Journal of Immunopharmacology","raw_type":"journal-article"},{"id":"pmid:3495501","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/3495501","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"International journal of immunopharmacology","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":0.9537000060081482}],"study_designs":[],"awards":[],"funders":[{"id":"https://openalex.org/F4320328499","display_name":"Narodowa Agencja Wymiany Akademickiej","ror":"https://ror.org/02jf81j23"}],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":38,"referenced_works":["https://openalex.org/W6891132","https://openalex.org/W25794465","https://openalex.org/W97582732","https://openalex.org/W102647449","https://openalex.org/W137925611","https://openalex.org/W631301279","https://openalex.org/W1506157243","https://openalex.org/W1529022422","https://openalex.org/W1853539513","https://openalex.org/W1968474143","https://openalex.org/W1971890827","https://openalex.org/W1975403142","https://openalex.org/W1983441105","https://openalex.org/W1993453403","https://openalex.org/W1994997120","https://openalex.org/W1995379504","https://openalex.org/W2011495061","https://openalex.org/W2029763810","https://openalex.org/W2034079944","https://openalex.org/W2050899380","https://openalex.org/W2055290101","https://openalex.org/W2061821710","https://openalex.org/W2070317421","https://openalex.org/W2080584272","https://openalex.org/W2085867374","https://openalex.org/W2116626052","https://openalex.org/W2118410952","https://openalex.org/W2123199679","https://openalex.org/W2142351400","https://openalex.org/W2145003612","https://openalex.org/W2148386904","https://openalex.org/W2154263532","https://openalex.org/W2164768020","https://openalex.org/W2168749358","https://openalex.org/W2402192458","https://openalex.org/W2429518082","https://openalex.org/W2438342101","https://openalex.org/W2464655907"],"related_works":["https://openalex.org/W2357037637","https://openalex.org/W2419395072","https://openalex.org/W2086669066","https://openalex.org/W2145003612","https://openalex.org/W2051998355","https://openalex.org/W2369942505","https://openalex.org/W2060105006","https://openalex.org/W102647449","https://openalex.org/W3100233797","https://openalex.org/W2061667020"],"abstract_inverted_index":null,"counts_by_year":[{"year":2013,"cited_by_count":1}],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2016-06-24T00:00:00"}